In-Vitro Release Testing — the Franz Diffusion Cell

For topical and transdermal dosage forms, conventional dissolution testing is generally inapplicable, since these products are not designed to fully...

For topical and transdermal dosage forms, conventional dissolution testing is generally inapplicable, since these products are not designed to fully dissolve or disperse but instead to release drug progressively across a membrane barrier over an extended application period. In-Vitro Release Testing, universally abbreviated IVRT, addresses this need through the use of a Franz diffusion cell, a two-compartment apparatus in which the formulation under test is applied to the donor compartment, separated from a receptor compartment by a membrane, with drug permeation across the membrane and into the receptor fluid monitored over time as a surrogate measure of release performance.

The membrane employed may be a synthetic material, most commonly cellulose acetate of 0.45 micrometre pore size or polysulfone, offering excellent reproducibility for formulation-discrimination purposes, or excised human or animal skin, providing a more physiologically representative but inherently more variable barrier, with the choice generally dictated by whether the study is intended to compare formulations or to predict actual in-vivo skin permeation. The receptor fluid is most commonly phosphate-buffered saline at pH 7.4, though for highly lipophilic drugs this may be supplemented with polyethylene glycol 400 to maintain adequate sink conditions for the permeated drug within the receptor compartment.

Temperature control is critical to obtaining physiologically meaningful results, with the receptor compartment maintained at 32 degrees Celsius through a water-jacketed cell design, reflecting the normal surface temperature of human skin rather than core body temperature, while continuous magnetic stirring of the receptor fluid, typically at 300 to 600 revolutions per minute, ensures homogeneous drug distribution and prevents the formation of localised concentration gradients that would compromise sampling accuracy. Samples are withdrawn from the receptor compartment at defined time points — commonly 0.5, 1, 2, 4, 6, 8, 12, and 24 hours — with each withdrawn volume immediately replaced by an equal volume of fresh receptor fluid to maintain constant total volume and sink conditions throughout the study.

Data analysis for IVRT studies conventionally proceeds by plotting the cumulative amount of drug permeated per unit membrane area against the square root of time, in accordance with the Higuchi diffusion model discussed in the following section, with the resulting slope providing a flux rate constant that serves as the primary metric for comparing the release performance of different formulations, supporting both formulation optimisation during development and post-approval change assessment through the Scale-Up and Post-Approval Changes, or SUPAC, regulatory framework.